Dealer’s choice: Further Seagen BD in cards as Merck on button, makes whopper bet Sep. 14, 2020 By Randy Osborne No Comments Though falling short of the outright takeover that some may have hoped for, Merck & Co. Inc.’s dual tie-ups with Seattle Genetics Inc. (Seagen) put the latter in solid position to shop for acquisitions of its own.Read More